Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Imigran

Known as: GSK Brand of Sumatriptan, Glaxo Wellcome Brand of Sumatriptan, Sumatriptan GSK Brand 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Histone methylation is associated with oocyte maturation in several species and is also expected in goat oocytes, while the… Expand
2014
2014
Sumatriptan (Imigran) is a potent and highly selective 5-HT1 receptor agonist often used in treating acute migraine. Intranasal… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2005
2005
Objective: To study the efficacy and practicality of treating headache in professional footballers with intranasal sumatriptan… Expand
  • table 1
  • table 2
2001
2001
Rizatriptan (MAXALTTM, a registered trademark of Merck & Co. Inc.) is a selective 5-HT1B/1D receptor agonist with rapid oral… Expand
  • figure 1
  • table 2
  • figure 2
  • figure 4
  • table 3
2000
2000
Sumatriptan, a 5HT1 receptor agonist, inhibits antral motor activity, delays gastric emptying and relaxes the gastric fundus. The… Expand
1999
1999
Migraine is a syndrome clinically manifested in attacks which dominant symptom is unilateral, rarely generalized, recurrent… Expand
1998
1998
Abstract The non-selective serotonin (5-HT) receptor agonist meta-chlorophenylpiperazine (mCPP) has been reported to elicit… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
1996
1996
Abstract In this double-masked, randomized, crossover, bioequivalence study, two 100-mg tablet preparations of sumatriptan… Expand
1994
1994
Sumatriptan (Imigran), an effective drug against symptoms of migraine may cause a sensation of thoracic oppression. In some… Expand
1992
1992
Developed for the treatment of migraine, sumatriptan is an agonist of 5-hydroxytryptamine-1-receptors. Though a pressure… Expand